| Welcome to the Tidyverse H Wickham, M Averick, J Bryan, W Chang, LDA McGowan, R François, ... Journal of open source software 4 (43), 1686, 2019 | 13786 | 2019 |
| Building predictive models in R using the caret package M Kuhn Journal of Statistical Software 28 (5), 1-26, 2008 | 8454 | 2008 |
| Applied predictive modeling M Kuhn, K Johnson Springer, 2013 | 8036 | 2013 |
| Feature engineering and selection: A practical approach for predictive models M Kuhn, K Johnson Chapman and Hall/CRC, 2019 | 856 | 2019 |
| Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis R Craig-Schapiro, M Kuhn, C Xiong, EH Pickering, J Liu, TP Misko, ... PloS one 6 (4), e18850, 2011 | 266 | 2011 |
| Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin, SE Arnold, ... Neurology 79 (9), 897-905, 2012 | 264 | 2012 |
| Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease HD Soares, WZ Potter, E Pickering, M Kuhn, FW Immermann, DM Shera, ... Archives of neurology 69 (10), 1310-1317, 2012 | 230* | 2012 |
| Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment WT Hu, A Chen-Plotkin, SE Arnold, M Grossman, CM Clark, LM Shaw, ... Acta neuropathologica 119, 669-678, 2010 | 203 | 2010 |
| Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways … RJ Kleiman, LH Kimmel, SE Bove, TA Lanz, JF Harms, A Romegialli, ... Journal of Pharmacology and Experimental Therapeutics 336 (1), 64, 2011 | 108 | 2011 |
| Tidy modeling with R M Kuhn, J Silge " O'Reilly Media, Inc.", 2022 | 98 | 2022 |
| Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes J Yang, ML MacDougall, MT McDowell, L Xi, R Wei, WJ Zavadoski, ... BMC genomics 12, 1-14, 2011 | 97 | 2011 |
| Accurate and fast feature selection workflow for high-dimensional omics data Y Perez-Riverol, M Kuhn, JA Vizcaíno, MP Hitz, E Audain PloS one 12 (12), e0189875, 2017 | 87 | 2017 |
| Postnatal PPARδ activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice BL Bernardo, TS Wachtmann, PG Cosgrove, M Kuhn, AC Opsahl, ... PLoS one 5 (6), e11307, 2010 | 79 | 2010 |
| Immuno-amplification J Nadeau, T Hellyer, D Berger, W Nussbaumer, R Rosenstein, A Kuhn, ... US Patent 7,932,060, 2011 | 78 | 2011 |
| Quantitative assessment of the impact of fluorine substitution on P-glycoprotein (P-gp) mediated efflux, permeability, lipophilicity, and metabolic stability M Pettersson, X Hou, M Kuhn, TT Wager, GW Kauffman, PR Verhoest Journal of medicinal chemistry 59 (11), 5284-5296, 2016 | 70 | 2016 |
| Ultra-sensitive measurement of IL-17A and IL-17F in psoriasis patient serum and skin C Soderstrom, G Berstein, W Zhang, H Valdez, L Fitz, M Kuhn, S Fraser The AAPS journal 19 (4), 1218-1222, 2017 | 58 | 2017 |
| Futility analysis in the cross-validation of machine learning models M Kuhn arXiv preprint arXiv:1405.6974, 2014 | 58 | 2014 |
| Homogeneous real-time detection of single-nucleotide polymorphisms by strand displacement amplification on the BD ProbeTec ET system SS Wang, K Thornton, AM Kuhn, JG Nadeau, TJ Hellyer Clinical chemistry 49 (10), 1599, 2003 | 56 | 2003 |
| Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studies TT Wager, BL Kormos, JT Brady, Y Will, MD Aleo, DB Stedman, M Kuhn, ... Journal of Medicinal Chemistry 56 (23), 9771-9779, 2013 | 51 | 2013 |
| The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to … A Thorarensen, P Balbo, ME Banker, RM Czerwinski, M Kuhn, TS Maurer, ... Bioorganic & Medicinal Chemistry 29, 115865, 2021 | 42 | 2021 |
